Search for the latest oncology news by tumour type
Genetic code change drives common lung cancer type
A team has identified a gene that drives development of the second most common type…
Browsing: Tumour Stream
New hormonal agent may slow progression of early-stage prostate cancer during active surveillance
For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent…
Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer
Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In…
First UK proton beam therapy trial for breast cancer launches
The first UK trial to test the benefits of proton beam therapy for certain patients with breast…
Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases
According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), ringlike peripheral high iodine…
Neoadjuvant immunotherapy leads to low recurrence in localised mismatch repair–deficient colorectal cancer
New research in the January 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds that…
Inflammation levels tied to severity of blood cancer
Severe inflammation weakens the body’s ability to kill cancerous blood cells in people with acute…
Side Effects of Breast Cancer Treatments: Q&A with Dr Nick Zdenkowski
Q: What are some of the most common side effects of breast cancer treatments? A:…
Sotorasib shows clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancer
In the Phase I/II CodeBreaK 100 trial, the KRAS G12C inhibitor sotorasib achieved meaningful anticancer activity…
FDA approves “glowing tumour” imaging drug to aid lung cancer surgery
The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent pafolacianine for use in…